A Case of Recurrent Rosai-Dorfman Disease Successfully Treated with 2-Chlorodeoxyadenosine (Cladribine)
10.15264/cpho.2019.26.2.99
- Author:
Min Hyung CHO
1
;
Hyun Joo JUNG
;
Jae Ho HAN
;
Jun Eun PARK
Author Information
1. Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea. pedpje@ajou.ac.kr
- Publication Type:Case Report
- Keywords:
Rosai-Dorfman disease;
2-Chlorodeoxyadenosine;
Refractory;
Recurrent
- MeSH:
Airway Obstruction;
Biopsy;
Child;
Cladribine;
Cytarabine;
Drug Therapy;
Dyspnea;
Emergencies;
Estrogens, Conjugated (USP);
Female;
Histiocytosis, Sinus;
Humans;
Lymph Nodes;
Lymphatic Diseases;
Methotrexate;
Neck;
Prednisone;
Radiotherapy;
Remission, Spontaneous;
Trachea;
Vinblastine;
Vincristine
- From:Clinical Pediatric Hematology-Oncology
2019;26(2):99-104
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sinus histiocytosis with massive lymphadenopathy, also known as Rosai-Dorfman disease (RDD), is a rare histiocytic disorder of unknown etiology. Most patients with RDD have spontaneous remission, but in some patients, the disease recurs after complete remission and may not respond to general treatment. Some patients with RDD involving the extranodal system can have serious symptoms such as vital organ dysfunction due to mass effects, neurological symptoms caused by intracranial involvement, and respiratory distress with airway involvement. We report the case of a 7-year-old girl with severe dyspnea due to refractory extranodal RDD that caused progressive upper airway obstruction. She was admitted because of nasal congestion and persistent cervical lymphadenopathy, and diagnosed as having RDD by cervical lymph node incisional biopsy. The initial prednisone treatment did not improve her symptoms. The following contrast-enhanced neck computed tomography revealed a newly developed airway mass protruding in the upper trachea. After 8 weeks of chemotherapy with vinblastine, methotrexate, and prednisone, complete remission was attained. Seven months after chemotherapy cessation, the disease recurred, and chemotherapy with vincristine, cytarabine, and prednisone was resumed. Despite the chemotherapy and emergency radiotherapy, no improvement was observed in the cervical lymph node enlargement and airway obstructive symptom due to the upper tracheal mass. 2-Chlorodeoxyadenosine (cladribine) therapy was initiated, and the patient got complete remission after 6 cycles of the cladribine treatment and maintained no evidence of disease for 2 years. We suggest that cladribine is an effective treatment option for recurrent/refractory RDD.
